The WHO criteria were designed to be used with disability adjusted life years.
The discounted cost per life year gained for adolescents and adults is US$334 and US$613, respectively. To calculate the number of life years gained, the study authors multiplied the discounted HIV infection averted at different ages by the life expectancy at that age group less the years of survival that would have in any case occurred with HIV and treatment availability (8 years plus 14 years = 22 years).
According to the WHO, the per-capita GDP, adjusted for the purchasing power parity of the country, can be used for setting thresholds for cost-effectiveness. Thus, interventions for which the additional cost incurred to gain one quality-adjusted life year is less than the country’s per-capita GDP are considered as very cost-effective.
Considering that GDP per capita in Rwanda (based on 2007 estimates) is US$355, male circumcision (MC) for adolescents is slightly less than one GDP/per capita/life year gained and therefore highly cost-effective, while MC for adults is less than two GDP/per capita/life year gained and therefore potentially cost-effective.